Nanjing Kati Medical Technology
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $11M
Investors
- 5
About Nanjing Kati Medical Technology
Based in Nanjing, China, and established in 2017, Nanjing Kati Medical Technology aka CART is a medical company that develops solid tumor CAR-T cell therapy and immune cell therapy. In July 2017, the company established the CMP platform. In 2018, its first clinical trial for patients with solid tumors was started. The company has formed dozens of product pipelines. Its R&D areas include DAP12 platform based CAR pipelines, CAR signal platform based on natural T cell receptors, CAR and TCR-T, lentivirus vectors, and CAR-T manufacturing.
Who invested in Nanjing Kati Medical Technology
5 investors across 2 rounds
See all investors in Nanjing Kati Medical Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nanjing Kati Medical Technology
Who invested in Nanjing Kati Medical Technology?
Nanjing Kati Medical Technology has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Kati Medical Technology raised?
Nanjing Kati Medical Technology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nanjing Kati Medical Technology last raise money?
Nanjing Kati Medical Technology's most recent round on record is a Series A, in Mar 2022.
What does Nanjing Kati Medical Technology do?
Based in Nanjing, China, and established in 2017, Nanjing Kati Medical Technology aka CART is a medical company that develops solid tumor CAR-T cell therapy and immune cell therapy.
Where is Nanjing Kati Medical Technology headquartered?
Nanjing Kati Medical Technology is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Kati Medical Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Nanjing Kati Medical Technology's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Nanjing Kati Medical Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.